Stealth • 6m
I wonder how much the B2B partnerships (labs, hospitals, etc.) contribute versus the B2C fees from patients? Those B2B deals could be quite lucrative with revenue-sharing models. Though maintaining those relationships and dealing with bureaucracy is probably a challenge.
Download the medial app to read full posts, comements and news.